Credit Suisse’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Credit Suisse’s Portfolio REUN Stock Details REUN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,542	Closed	-$1.39K	–	3883
2022 Q4	$1.39K	Hold	1,542	–	–	﹤0.01%	3564
2022 Q3	$2K	Buy	+1,542	New	+$5.48K	﹤0.01%	3783

Other funds holding REUN

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

OPOWM

One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $1.83B AUM 18.28% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Credit Suisse's REUN Position: Q1 2023 in Review

Credit Suisse sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q1 2023, closing a stake of 1,542 shares — an estimated $1.39K sold.

Credit Suisse first reported a position in REUN in Q3 2022 and held it in 2 quarters. The position peaked at $2K in Q3 2022. 26 funds tracked by Wall St. Rank hold REUN as of Q1 2023.

Credit Suisse reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 1,542 Reunion Neuroscience Inc. Common Shares shares in Q1 2023, an estimated $1.39K.
Credit Suisse first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2022 and held it in 2 quarters.
Credit Suisse's Reunion Neuroscience Inc. Common Shares position peaked at $2K in Q3 2022.
26 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.